Photodynamic therapy mediated induction of accelerated re- endothelialisation following injury to the arterial wall: Implications for the prevention of postinterventional restenosis

European Journal of Vascular and Endovascular Surgery

Volumn 24, Issue 2, 2002, Pages 166-175

  Adili, F ^a,c   Scholz, T ^a   Hille, M ^a   Heckenkamp, J ^b   Barth, S ^b   Engert, A ^b   Schmitz Rixen, T ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c NONE   (Germany)

Author keywords

bFGF; Endothelial cells; Photodynamic therapy; Restenosis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY WALL; ARTICLE; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; RESTENOSIS; ANIMAL; CAROTID ARTERY INJURY; DISEASE MODEL; DRUG EFFECT; GENETICS; INJURY; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; RADIATION EXPOSURE; SPRAGUE DAWLEY RAT; TIME; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; PHOTOCHEMOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; WOUND HEALING;

EID: 0036691346     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1703     Document Type: Article

References (43)

1. ISNER JM, ASAHARA T, LOSORDO DW, VALE P. Pro-endothelial cell approach to restenosis. In: Rothman MT, ed. Restenosis: Multiple Strategies for Stent Drug Delivery. London: ReMEDICA Publishing, 2001; 55-81.
2. DAVIES MG. Pathobiology of intimal hyperplasia. Br J Surg 1994; 81: 1254-1269.
3. YAYON A, KLAGSBRUN M. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cancer Met Rev 1990; 9: 191-202.
4. HAIMOVITZ-FRIEDMAN A, VLODAVSKI I, CHAUDHURI A, WITTE L, FUKS Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 1991; 51: 2552-2558.
5. LINDNER V, REIDY MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries: an en face study. Circ Res 1993; 73: 589-595.
6. BIRO S, YU ZX, FU YM et al. Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells. Circ Res 1994; 74: 485-494.
7. Ross R. Atherosclerosis: a defense mechanism gone awry. Am J Pathol 1993; 143: 987-1002.
8. ASAHARA T, BAUTERS C, PASTORE C et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793-2801.
9. ASAHARAT, CHEN D, TSURUMI Y et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 1996; 94: 3291-3302.
10. LINDNER V, MAJACK RA, REIDY MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990; 85: 2004-2008.
11. LAMURAGLIA GM, CHANDRASEKAR NR, FLOTTE TJ et al. Photodynamic therapy inhibition of experimental intimal hyperplasia: acute and chronic effects. J Vasc Surg 1994; 19: 321-331.
12. LAMURAGLIA GM, ADILI F, KARP SJ, STATIUS VAN EPS RG, WATKINS MT. Photodynamic therapy inactivates extracellular matrix-basic fibroblast growth factor: insights to its effect on the vascular wall. J Vasc Surg 1997; 26: 294-301.
13. STATIUS VAN EPS RG, ADILI F, WATKINS MT, ANDERSON RR, LAMURAGLIA GM. Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-β. Lab Invest 1997; 76: 257-266.
14. STATIUS VAN EPS RG, ADILI F, WATKINS MT, ANDERSON RR, LAM RAGLIA GM. PDT inhibits matrix-associated TGF-beta. Lab Invest 1997; 76: 257-266.
15. ADILI F, STATIUS VAN EPS RG, KARP SJ, WATKINS MT, LAMURAGLIA GM. Differential modulation of vascular endothelial and smooth muscle cell function by photodynamic therapy of extracellular matrix: novel insights into radical-mediated pre-vention of intimal hyperplasia. J Vasc Surg 1996; 23: 698-705.
16. BOULNOIS JL. Photophysical process in recent medical laser development: a review. Lasers Med Sci 1986; 1: 47-66.
17. NEWMAN PJ. Cell adhesion in vascular biology. The biology of PECAM-1. J Clin Invest 1997; 99: 3-8.
18. VLODAVSKY I, FOLKMAN J, SULLIVAN R et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987; 84: 2292-2296.
19. ASSELIN E, DROLET P, FORTIER MA. Cellular mechanisms involved during oxytocin-induced prostaglandin F2alpha production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Endocrinology 1997; 138: 4798-4805.
20. DI BLASIO AM, VIGANO P, CREMONESI L et al. Expression of genes encoding basic fibroblast growth factor and its receptor in human granulosa cells. Mol Cel Endocrinol 1993; 96: 7-11.
21. ABRAHAM JA, MERGIA A, WHANG JL et al. Cellular mechanisms involved during oxytocin-induced prostaglandin F2alpha production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Endocrinology 1997; 138: 4798-4805.
22. ETON D, COLBURN MD, SHIM V et al. Inhibition of intimal hyperplasia by photodynamic therapy using photofrin. J Surg Res 1992; 53: 558-562.
23. ORTU P, LAMURAGLIA GM, ROBERTS WG, FLOTTE TJ, HASAN T. Photodynamic therapy of arteries. A novel approach for treatment of intimal hyperplasia. Circulation 1992; 85: 1189-1196.
24. NYAMEKYE I, ANGLIN S, MCEWAN J et al. Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid. Circulation 1995; 91: 417-425.
25. LAMURAGLIA GM, ORTU P, FLOTTE TJ et al. Chloroaluminum sulfonated phthalocyanine partitioning in normal and intimal hyperplastic artery in the rat. Implications for photodynamic therapy. Am J Pathol 1993; 142: 1898-1905.
26. STATIUS van EPS RG, CHANDRASEKAR NR, LAMURAGLIA GM. Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia. Photochem Photobiol 1998; 67: 337-342.
27. STATIUS van EPS RG, LAMURAGLIA GM. Photodynamic therapy inhibits transforming growth factor β activity associated with smooth muscle cell injury. J Vasc Surg 1997; 25: 1044-1053.
28. KORNER G, BJORNSSON TD, VLODAVSKY I. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. J Cell Physiol 1993; 154: 456-463.
29. ROGELJ S, KLAGSBRUN M, ATZMON R et al. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J Cell Biol 1989; 109: 823-831.
30. LAMURAGLIA GM, SCHIERECK J, HECKENKAMP J et al. Photodynamic therapy induces apoptosis in intimal hyperplastic arteries. Am J Pathol 2000; 157: 867-875.
31. GRANT WE, BUONACCORSI G, SPEIGHT PM et al. The effect of photodynamic therapy on the mechanical integrity of normal rabbit carotid arteries. Laryngoscope 1995; 105: 867-871.
32. OVERHAUS M, HECKENKAMP J, KOSSODO S, LESZCZYNSKI D, LAMURAGLIA GM. Photodynamic therapy generates a matrix barrier to invasive vascular cell migration. Circ Res 2000; 86: 334-340.
33. VLODAVSKY I, FRIDMAN R, SULLIVAN R, SASSE J, KLAGSBRUN M. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol 1987; 131: 402-408.
34. GAJDUSEK CM, CARBON S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol 1989; 139: 570-579.
35. ARESE M, CHEN Y, FLORKIEWICZ RZ et al. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol Biol Cell 1999; 10: 1429-1444.
36. 1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem 1996; 271: 29822-29829.
37. TSUBOI R, SATO Y, RIFKIN DB. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 1990; 110: 511-517.
38. GUALANDRIS A, RUSNATI M, BELLERI M et al. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ 1996; 7: 147-160.
39. BAIRD A. Potential mechanism regulating the extracellular activ-ities of basic fibroblast growth factor (FGF-2). Mol Reprod Dev 1994; 39: 43-48.
40. ADILI F, STATIUS VAN EPS RG, LAMURAGLIA GM. Local delivery of photosensitizing drugs in arteries: a novel approach to photo-dynamic therapy for the prevention of intimai hyperplasia. In: Proc Laser Surg. Bellingham, Washington: SPIE; 1995: 402-408.
41. ADILI F, STATIUS VAN EPS RG, FLOTTE TJ, LAMURAGLIA GM. Photodynamic therapy with local photosensitizer delivery inhibits experimental intimai hyperplasia. Lasers Surg Med 1998; 23: 263-273.
42. WEICH HA, IBERG N, KLAGSBRUN M, FOLKMAN J. Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. J Cell Biochem 1991; 47: 158-164.
43. WEMPE F, LINDNER V, AUGUSTIN HG. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells 1997; 17: 2471-2478.